Browsing: Health

GENEVA: The World Health Organization has granted prequalification to an additional novel oral polio vaccine type 2, expanding the pool of quality assured vaccines that can be bought for international immunization programmes and deployed in outbreak settings. WHO said the decision confirms the vaccine meets its standards for quality, safety and efficacy and enables procurement through United Nations agencies, including UNICEF, for use by countries and partners responding to poliovirus transmission. Prequalification is a gatekeeping step used by global health agencies to guide large scale purchases and support regulatory decision making in lower income and emergency contexts. WHO said the newly prequalified vaccine is designed…

WASHINGTON: The U.S. Food and Drug Administration has declined to accept for review Moderna’s application to license its seasonal influenza vaccine candidate mRNA-1010, issuing a refusal-to-file letter that stops the agency’s formal review process at the filing stage. Moderna said the FDA’s Center for Biologics Evaluation and Research sent the notice on Feb. 3, and the company disclosed the decision on Feb. 10. Moderna shares fell about 8% in after-hours trading after the disclosure. Moderna said the refusal-to-file letter cited a single issue, the choice of comparator used in a pivotal late-stage study, and did not raise safety or effectiveness concerns about mRNA-1010. The company…

MENA Newswire, WASHINGTON: U.S. regulators have classified a recall affecting more than 80,000 single serve coffee pods made for Keurig brewers after a labeling error raised concerns for consumers who avoid caffeine. The action covers McCafé Premium Roast Decaf Coffee K-Cup pods distributed by Keurig Dr Pepper, according to the U.S. Food and Drug Administration’s recall listing. The FDA categorized the action as a Class II recall on Jan. 23, 2026. A Class II classification is used when use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or when the likelihood of serious adverse health consequences is remote.…

INDIANAPOLIS, December 12, 2025: Eli Lilly and Co. announced that its next-generation obesity drug, retatrutide, achieved significant weight loss and reduced knee pain in a late-stage Phase 3 trial, underscoring its potential as a major advance in obesity and osteoarthritis treatment. The TRIUMPH-4 study evaluated retatrutide, a triple-hormone receptor agonist that activates GLP-1, GIP, and glucagon pathways, in adults with obesity and knee osteoarthritis. Participants receiving the highest dose of the drug lost an average of 28.7 percent of their body weight after 68 weeks of treatment, equivalent to approximately 71 pounds. Those receiving placebo lost an average of 2.1 percent…

Glenmark recalls 11000 Ziac bottles after FDA finds contamination with cholesterol drug ezetimibe, classifying it as a low-risk Class III recall.

FDA widens recall of imported cookware after lead found to leach into food, urging U.S. consumers to stop using contaminated pots and pans.

MIT scientists have discovered a retinal reboot method that restores vision in amblyopia, offering new hope for treating adult lazy eye.

WASHINGTON, November 8, 2025: The United States Department of State has issued new instructions to consular offices worldwide expanding the list of medical conditions that may lead to visa denials. Under the updated guidance, chronic illnesses including obesity, diabetes, and cardiovascular disease are now among the factors that visa officers can consider when determining whether an applicant may become a “public charge” and therefore ineligible for entry or permanent residency. The directive, recently circulated to U.S. embassies and consulates, broadens the interpretation of existing immigration law governing applicants who could require extensive medical treatment or financial support while in the country. The new…

FDA recalls over 580,000 bottles of Prazosin Hydrochloride after tests found a cancer-linked impurity exceeding safety limits.

Idaho’s Medical Freedom Act bans all vaccine mandates statewide, redefining vaccination rules for schools, employers, and public institutions.